BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs2476601, NEUROG3, T cell differentiation, Pseudomonas infection, Kidney, Alcohol)
Bookmark Forward

QuickView for cholesterol efflux (biogroup)


Body Atlas

Most Correlated Tissues

  1. Liver
  2. Fetal liver
  3. Adrenal gland cortex
  4. Ileum mucosa
  5. Fetal lung
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Encephalomyelitis
  2. Sitosterolemia
  3. Familial hypoalphalipoproteinemia
  4. Fusarium infection
  5. Enteritis of small intestine
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. CGP 60474
  2. trichlorofluoromethane
  3. senkirkine
  4. N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine
  5. BMS 777607
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. INSM2
  2. RNASEH2B
  3. LPAR3
  4. HMOX2
  5. LPAR1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. Embryonic stem cells and iPSCs with homozygous mutant AAT during hepatic directed differentiation
  2. Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) expression profiles
  3. L1000 CMAP - Melanoma A375 cells with CRISPR-targeted gene knockouts
  4. L1000 CMAP - Embryonic stem HUES3 cells treated with small molecule perturbagens
  5. Liver cells overexpressing YAP
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. MicroRNA-320b Modulates Cholesterol Efflux and Atherosclerosis.
  2. High-Density Lipoprotein Cholesterol Efflux Capacity as a Novel Prognostic Surrogate for Coronary Ar…
  3. Impaired cholesterol efflux capacity in patients with Helicobacter pylori infection and its relation…
  4. Cholesterol efflux capacity in coronary artery disease: a meta-analysis.
  5. Anthocyanin supplementation at different doses improves cholesterol efflux capacity in subjects with…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. the Change of Cholesterol Efflux Capacity and Coronary Artery Disease in Real Clinical Practice
  2. The Genetic, Protein, and Lipid Basis of Variation in Cholesterol Efflux
  3. Impaired HDL and Coronary Artery Disease in Anabolic Androgenic Steroid Users
  4. Effect of Niaspan on Cholesterol in Men
  5. Ezetimibe Reverse Cholesterol Transport (RCT) Pilot Study
Explore Clinical Trials Results
  • Copyright © 2021 Illumina Inc. All rights reserved.